The 180-day exclusivity rule under the Hatch-Waxman Act rewards generic drugmakers for challenging patents-but it can delay market entry for years. Learn how it works, who benefits, and why reform is needed.
Read More
The 180-day exclusivity rule under the Hatch-Waxman Act rewards generic drugmakers for challenging patents-but it can delay market entry for years. Learn how it works, who benefits, and why reform is needed.
Read More